Efficacy of interferon treatment for patients with chronic hepatitis C: Comparison of response in cirrhotics, fibrotics, or nonfibrotics
Author:
Publisher
Wiley
Subject
Hepatology
Reference13 articles.
1. Clinical Outcomes after Transfusion-Associated Hepatitis C
2. Natural history of liver fibrosis progression in patients with chronic hepatitis C
3. To C or not to C: these are the questions
4. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
5. Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis
Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Historical Overview on the Role of Hepatitis B and C Viruses as Aetiological Factors for Hepatocellular Carcinoma;Cancers;2023-04-20
2. Risk Factors for Liver Decompensation and HCC in HCV-Cirrhotic Patients after DAAs: A Multicenter Prospective Study;Cancers;2021-07-29
3. Risk stratification of HCC occurrence after HCV eradication: a complicate plot of risk factors related and unrelated to the previous viral disease;Hepatobiliary Surgery and Nutrition;2020-08
4. Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens;PLOS ONE;2017-05-18
5. Managing patients with hepatitis-B-related or hepatitis-C-related decompensated cirrhosis;Nature Reviews Gastroenterology & Hepatology;2011-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3